Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT01154985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a controlled study to determine the effectiveness and safety of ethyl icosapentate (EPA-E) in the treatment of adult patients with non-alcoholic steatohepatitis (NASH).
Study identification
- NCT ID
- NCT01154985
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Oct 2012 (Actual)
- Last update posted
- Nov 20, 2014
2010 – 2012
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mochida Investigative Site | Dothan | Alabama | 36305 | — |
| Mochida Investigative Site | Tucson | Arizona | 85712 | — |
| Mochida Investigative Site | Anaheim | California | 92801 | — |
| Mochida Investigative Site | Coronado | California | 92118 | — |
| Mochida Investigative Site | La Jolla | California | 92037 | — |
| Mochida Investigative Site | Los Angeles | California | 90048 | — |
| Mochida Investigative Site | San Diego | California | 92123 | — |
| Mochida Investigative Site | San Diego | California | 92161 | — |
| Mochida Investigative Site | Littleton | Colorado | 80120 | — |
| Mochida Investigative Site | Hialeah | Florida | 33016 | — |
| Mochida Investigative Site | Chicago | Illinois | 60612 | — |
| Mochida Investigative Site | Lexington | Kentucky | 40536 | — |
| Mochida Investigative Site | New Orleans | Louisiana | 70112 | — |
| Mochida Investigative Site | Chevy Chase | Maryland | 20815 | — |
| Mochida Investigative Site | Detroit | Michigan | 48202 | — |
| Mochida Investigative Site | Plymouth | Minnesota | 55446 | — |
| Mochida Investigative Site | Jackson | Mississippi | 39202 | — |
| Mochida Investigative Site | Tupelo | Mississippi | 38801 | — |
| Mochida Investigative Site | Plainview | New York | 11803 | — |
| Mochida Investigative Site | Asheville | North Carolina | 28801 | — |
| Mochida Investigative Site | Durham | North Carolina | 27713 | — |
| Mochida Investigative Site | Cincinnati | Ohio | 45219 | — |
| Mochida Investigative Site | Cincinnati | Ohio | 45242 | — |
| Mochida Investigative Site | Cleveland | Ohio | 44195 | — |
| Mochida Investigative Site | Providence | Rhode Island | 02903 | — |
| Mochida Investigative Site (2 sites) | Germantown | Tennessee | 38138 | — |
| Mochida Investigative Site | Nashville | Tennessee | 37211 | — |
| Mochida Investigative Site | Houston | Texas | 77005 | — |
| Mochida Investigative Site (2 sites) | Houston | Texas | 77030 | — |
| Mochida Investigative Site | San Antonio | Texas | 78234 | — |
| Mochida Investigative Site | Newport News | Virginia | 23602 | — |
| Mochida Investigative Site | Richmond | Virginia | 23298 | — |
| Mochida Investigative Site | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01154985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01154985 live on ClinicalTrials.gov.